实时全球研报
HSD 2.0 – Safe Before Sharp
研报英文原文证据摘录
HSD 2.0 – Safe Before Sharp
Idea
July 15, 2026 04:41 AM GMT
Morgan Stanley Asia Limited+MHorizon Robotics | Asia Pacific Tim Hsiao
Equity Analyst
HSD 2.0 – Safe Before Sharp Tim.Hsiao@morganstanley.comPeggy Wang +852 2848-1982
Research Associate
Peggy.Pc.Wang@morganstanley.com +852 3963-3934
We attended Horizon’s HSD 2.0 test ride and mgmt meeting. Shelley Wang, CFA
HSD 2.0 was assured in most scenarios but hesitant in complex Equity Analyst
Shelley.Wang@morganstanley.com +852 3963-0047
ones that should benefit from data training. With order concerns Joey Xu, CFA
largely discounted, we think the stock needs a trigger rather EquityJoey.Xu@morganstanley.comAnalyst +852 3963-0337
than a floor. Stay OW.
Stock priced for doubt, awaiting a trigger: The stock setup is range-bound in the
near term in our view, as the anemic 1H print and lack of a near-term catalyst or
valuation anchor should constrain the shares until there is greater clarity on the per-
vehicle content impact of the shift from hardware to licensing and design-win upside Horizon Robotics (9660.HK, 9660 HK)
at anchor customers, like BYD. We think the negatives are largely discounted, but a China Autos & Shared Mobility | China
catalyst is still missing. We will monitor J6/Starry 6P cadence, iCAR-to-mainstream Stock Rating Overweight
Industry View In-Line
progress, and project win quantification. Price target HK$8.70
Up/downside to price target (%) 97
Our test-ride in Shenzhen suggests the system performs smoothly on highways Shr price, close (Jul 14, 2026) HK$4.42
52-Week Range HK$11.32-3.60
and wide urban roads without being overly aggressive or conservative. However, it
Sh out, dil, curr (mn) 14,652
tends to hesitate for extended periods in complex scenarios, such as navigating Mkt cap, curr (mn) Rmb56,004.1
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器